On 29 January in Milan, we took part in the BioPharma Network Annual Summit, a key event focused on the transformation of the pharmaceutical sector, sharing the stage with institutions and industry leaders such as AIFA, Farmindustria and leading global pharma companies.

During the Innovation Panel, our CEO, Francesca Gabrielli, presented an exclusive preview of the first insights from ACT4AI – Observatory and Actions for Digital and AI Adoption in Pharma, the collaborative lab developed together with BioPharma Network to accelerate the adoption of AI and digital technologies across the pharma ecosystem.

Despite the rapid advancement of AI, its adoption still faces significant barriers: legacy systems, data quality issues, skills gaps, regulatory uncertainty and cultural resistance. In this context, the contribution focused on a concrete, data-driven approach to turning AI’s potential into measurable impact.

Giacomo Porzio, CEO of Hyntelo, our AI solutions company, also joined the event, exploring the growing role of AI and Agentic AI in enabling new operating models across the industry.

As a CX Transformation Company, we support pharmaceutical organisations in creating the conditions to scale innovation, actively contributing to the sector’s evolution towards a more structured, coherent and high-impact digital future.